{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:13:23Z","timestamp":1792548803431,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.semnephrol.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T08:30:18Z","timestamp":1509093018000},"page":"538-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["The Cell Biology of APOL1"],"prefix":"10.1016","volume":"37","author":[{"given":"John F.","family":"O\u2019Toole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sethu","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Sedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2017.07.007_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molbiopara.2004.07.004","article-title":"Characterization of primate trypanosome lytic factors","volume":"138","author":"Lugli","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/geno.2001.6534","article-title":"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution","volume":"74","author":"Page","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib7","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1681\/ASN.2015101121","article-title":"Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based cohort","volume":"27","author":"Kozlitina","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrmicro3298","article-title":"The molecular arms race between African trypanosomes and humans","volume":"12","author":"Pays","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.1156296","article-title":"A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans","volume":"320","author":"Vanhollebeke","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.126.1.155","article-title":"Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes","volume":"126","author":"Hager","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib12","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1074\/jbc.M900151200","article-title":"Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein","volume":"284","author":"Harrington","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela Mdel","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib14","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.M115.680371","article-title":"Trypanosome lytic factor-1 initiates oxidation-stimulated osmotic lysis of Trypanosoma brucei brucei","volume":"291","author":"Greene","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib15","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/ncomms9078","article-title":"Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1","volume":"6","author":"Vanwalleghem","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/EC.05112-11","article-title":"Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity","volume":"10","author":"Stephens","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib17","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M503510200","article-title":"Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes","volume":"280","author":"Shiflett","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib18","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","article-title":"Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene","volume":"42","author":"Duchateau","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/geno.2002.6729","article-title":"The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue","volume":"79","author":"Monajemi","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib25","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib27","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib29","doi-asserted-by":"crossref","first-page":"e0153768","DOI":"10.1371\/journal.pone.0153768","article-title":"Knockdown of ApoL1 in Zebrafish larvae affects the glomerular filtration barrier and the expression of nephrin","volume":"11","author":"Kotb","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4161\/auto.7066","article-title":"ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death","volume":"4","author":"Zhaorigetu","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib31","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib33","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects","volume":"27","author":"Sampson","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib35","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib36","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.M059733","article-title":"Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells","volume":"56","author":"Cheng","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib37","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1152\/ajpcell.00384.2014","article-title":"Exon 4 encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1","volume":"309","author":"Khatua","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib39","doi-asserted-by":"crossref","first-page":"C332","DOI":"10.1152\/ajpcell.00142.2015","article-title":"BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins","volume":"309","author":"Heneghan","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib40","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib41","doi-asserted-by":"crossref","first-page":"e1005349","DOI":"10.1371\/journal.pgen.1005349","article-title":"In vivo modeling implicates APOL1 in nephropathy: evidence for dominant negative effects and epistasis under anemic stress","volume":"11","author":"Anderson","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib42","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-006-6091-x","article-title":"The function of apolipoproteins L","volume":"63","author":"Vanhollebeke","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib43","doi-asserted-by":"crossref","first-page":"e51546","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib44","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1681\/ASN.2013080859","article-title":"Estimating podocyte number and density using a single histologic section","volume":"25","author":"Venkatareddy","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semnephrol.2015.04.004","article-title":"Podometrics as a potential clinical tool for glomerular disease management","volume":"35","author":"Kikuchi","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib47","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1073\/pnas.0601437104","article-title":"Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae","volume":"104","author":"Gutierrez","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00430-010-0163-0","article-title":"Pro-autophagic signal induction by bacterial pore-forming toxins","volume":"199","author":"Kloft","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbrc.2009.05.121","article-title":"Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium","volume":"385","author":"Kloft","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0100-879X2008005000049","article-title":"The role of stress-activated protein kinase signaling in renal pathophysiology","volume":"42","author":"Ma","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI200421004","article-title":"Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways","volume":"114","author":"He","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib52","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1681\/ASN.2008080879","article-title":"Reduction of Stat3 activity attenuates HIV-induced kidney injury","volume":"20","author":"Feng","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/QAD.0b013e32835f1ea1","article-title":"Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy","volume":"27","author":"Gu","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib54","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib55","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","article-title":"Renal epithelium is a previously unrecognized site of HIV-1 infection","volume":"11","author":"Bruggeman","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib56","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm0502-522","article-title":"Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy","volume":"8","author":"Marras","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2017.07.007_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12977-015-0165-5","article-title":"Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses","volume":"12","author":"McLaren","year":"2015","journal-title":"Retrovirology"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T17:47:07Z","timestamp":1659721627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929517300736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0270929517300736"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cell Biology of APOL1","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}